Bipolar depression can be particularly difficult to treat. The depressive phase may bring persistent sadness, loss of motivation, hopelessness, anxiety, sleep disruption, and, in severe cases, suicidal thinking. Yet treating bipolar depression is not simply a matter of finding a stronger antidepressant. Any treatment has to account for the underlying bipolar disorder and the possibility of shifting the patient toward mania or hypomania.
That is part of what makes ketamine an interesting, and still developing, area of psychiatric care.
Research into ketamine for bipolar depression is not as extensive as research into ketamine for unipolar major depression. But clinical studies and systematic reviews have found signals worth paying attention to, particularly for people whose depressive symptoms have not responded adequately to conventional treatment. (PubMed Central (PMC))
At Chicago IV Solution, bipolar disorder is among the diagnoses considered within its ketamine treatment and veteran referral programs. The Chicago clinic provides IV ketamine under medical supervision and has reported extensive experience with ketamine infusions. (Chicago IV Solution)
The important question, then, isn’t simply whether ketamine “works” for bipolar depression. It is where ketamine may fit into treatment, who may be an appropriate candidate, and why careful medical oversight matters.
Bipolar Depression Is Different From Major Depression
Bipolar disorder is characterized by episodes of depression as well as periods of mania or hypomania, depending on the type of bipolar disorder.
That distinction matters when considering bipolar depression treatment.
A person experiencing a depressive episode may look, on the surface, much like someone with major depressive disorder: low mood, fatigue, withdrawal, difficulty concentrating, changes in sleep or appetite, and diminished interest in previously enjoyable activities.
But the treatment history and broader pattern of mood episodes tell a different story.
Someone with bipolar disorder may have previously experienced unusually elevated or irritable mood, decreased need for sleep, increased energy, racing thoughts, impulsivity, or other symptoms associated with mania or hypomania. A treatment approach therefore has to consider the entire mood disorder rather than treating the current depressive episode in isolation.
This is one reason ketamine treatment for bipolar depression should be considered as part of a broader psychiatric treatment plan—not as a replacement for appropriate diagnosis and mood-stabilizing care.
Why Is Ketamine Being Studied for Bipolar Depression?
Traditional antidepressants primarily work through neurotransmitter systems involving serotonin, norepinephrine, and dopamine. Ketamine works differently.
At a simplified level, ketamine influences the brain’s glutamate system, including NMDA receptors. This can produce downstream changes associated with synaptic plasticity—the brain’s ability to modify connections between nerve cells.
That mechanism has attracted considerable interest because ketamine can produce antidepressant effects more rapidly than many conventional antidepressant medications.
The research question is whether that effect can also help people experiencing bipolar depression, particularly when conventional treatments have not provided sufficient relief.
So far, the answer appears promising but incomplete.
An updated systematic review published in 2023 identified eight studies involving 235 people with bipolar disorder. In the studies involving IV ketamine, treatment was generally used alongside a mood-stabilizing medication. The review found that 48% of participants receiving ketamine met the study definition of response, compared with 5% receiving placebo. The authors nevertheless emphasized that additional research is needed. (PubMed Central (PMC))
Those numbers should not be interpreted as a guarantee that an individual patient will respond. The studies were relatively small, and research designs, treatment schedules, and patient populations varied.
But they help explain why ketamine has become an area of serious clinical interest.
What Does Ketamine Infusion for Bipolar Depression Involve?
IV ketamine is administered through an intravenous line while the patient remains under medical observation.
At Chicago IV Solution, the clinic describes its mental-health ketamine treatment as an individualized IV program. Its published information says treatment sessions generally last approximately 40 minutes to an hour, with vital signs monitored during treatment and an observation period afterward. (Chicago IV Solution)
Patients can experience temporary changes in perception or consciousness during an infusion. Dissociation is one of the effects associated with ketamine and can feel unfamiliar, although it generally resolves as the medication wears off. (Chicago IV Solution)
This is also why an infusion should not be viewed as something comparable to taking a conventional medication at home. The setting, monitoring, dose selection, medical history, current medications, and response during treatment all matter.
After treatment, patients should have transportation arranged and should not drive themselves home.
The Bipolar-Specific Safety Question: Could Ketamine Trigger Mania?
This is one of the most important questions for anyone researching ketamine for bipolar depression.
The concern is legitimate.
People with bipolar disorder can experience shifts from depression into mania or hypomania, and clinicians need to distinguish a potential mood switch from the temporary perceptual or emotional effects that can occur during ketamine treatment.
Available research has not demonstrated that manic switching is common, but it has been reported. An earlier systematic review found manic symptoms in two participants across the studies it examined. (OUP Academic)
A later review likewise found reports of manic or hypomanic switching in some patients, including a real-world study in which three of 66 patients developed hypomania after later ketamine infusions. (PubMed Central (PMC))
At the same time, the broader evidence remains limited. The updated review concluded that ketamine appeared generally tolerable in the available studies, while noting that the evidence base is still relatively small. (PubMed Central (PMC))
The practical takeaway is straightforward: bipolar disorder makes careful screening and monitoring particularly important.
Ketamine should not be treated as a self-directed experiment. A qualified medical team needs to consider the patient’s psychiatric history, current medications, previous manic or hypomanic episodes, cardiovascular health, substance-use history, and other relevant factors before treatment.
Does Ketamine Replace Mood Stabilizers?
Not necessarily—and the research does not support treating ketamine as a substitute for comprehensive bipolar care.
In the IV ketamine studies included in the major systematic reviews, participants generally received ketamine as an adjunctive treatment while continuing a mood-stabilizing medication. (PubMed Central (PMC))
That distinction is important.
Ketamine may be investigated as an additional tool for depressive symptoms rather than as a medication that addresses every aspect of bipolar disorder.
For someone considering ketamine treatment for bipolar depression, the conversation should therefore include the psychiatrist or other clinician managing the person’s bipolar disorder. Current medications should not be stopped or changed simply because ketamine is being considered.
What Might Make Someone a Candidate?
There is no single checklist that determines whether someone should receive ketamine.
Clinicians generally need to look beyond the diagnosis itself. The nature and severity of the depressive episode, previous treatment response, psychiatric history, current medications, physical health, substance-use history, and the presence or absence of manic symptoms can all influence the decision.
Treatment-resistant symptoms may be particularly relevant because much of the research has focused on people who have not obtained adequate relief from conventional approaches. (PubMed)
The goal is not to find the most aggressive treatment available. It is to determine whether a particular treatment makes sense for a particular patient.
That distinction becomes especially important with bipolar disorder.
What Does the Evidence Tell Us About How Long Benefits Last?
This is an area where expectations need to remain realistic.
Some studies have found relatively rapid improvement in depressive symptoms after ketamine, but the duration of benefit varies. The earlier systematic review noted that the antidepressant effect from a single dose did not clearly extend beyond two weeks, while a study involving multiple doses suggested a longer-lasting effect. (OUP Academic)
That is one reason researchers continue to study repeated and maintenance treatment strategies.
It also explains why ketamine treatment is better understood as part of an ongoing treatment plan rather than a one-time procedure that permanently eliminates bipolar depression.
The appropriate schedule, if treatment is pursued, needs to be determined individually by the treating medical team.
How IV Ketamine Fits Into Chicago IV Solution’s Approach
Chicago IV Solution describes its ketamine program as personalized IV therapy delivered in a medically supervised setting. The clinic’s medical director, Dr. Bal Nandra, is an anesthesiologist trained at the University of Chicago Hospitals Department of Anesthesia and Critical Care. The practice says it has administered more than 15,000 ketamine infusions since 2017. (Chicago IV Solution)
The clinic also describes collaboration with patients’ primary-care physicians, specialists, and mental-health professionals to support continuity of care. (Chicago IV Solution)
That multidisciplinary approach is particularly relevant when discussing bipolar depression. Ketamine does not exist separately from the rest of a person’s mental-health treatment. Medication management, psychiatric follow-up, psychotherapy, sleep, substance use, and monitoring for mood changes can all remain important.
For patients who are considering treatment, Chicago IV Solution offers a consultation process to determine whether its approach is appropriate. (Chicago IV Solution)
A More Realistic Way to Think About Ketamine for Bipolar Depression
Ketamine is neither a miracle cure nor a treatment that should be dismissed because the research is still developing.
The evidence so far suggests that IV ketamine may have antidepressant effects for some people with bipolar depression, including people who have struggled with treatment-resistant symptoms. But the available studies are relatively small, longer-term evidence remains limited, and safety considerations, particularly mood switching, deserve careful attention. (PubMed Central (PMC))
That leaves ketamine in an interesting position: promising enough to warrant serious clinical consideration, but not established enough to remove the need for individualized assessment.
For someone living through a persistent bipolar depressive episode, that distinction matters. The right question isn’t simply, “Can ketamine treat bipolar depression?”
It is whether ketamine infusion therapy, under appropriate medical supervision and alongside a broader treatment plan, could be a reasonable option for that individual.
For anyone exploring that possibility in Chicago, a consultation with our qualified medical team is the appropriate place to begin: Chicago IV Solution